Vaccination Coverage Among U.S. Adolescents Aged 13-17 Years Eligible for the Vaccines for Children Program, 2009
Vaccination Coverage Among U.S. Adolescents Aged 13-17 Years Eligible for the Vaccines for Children Program, 2009
复制标题
DOI：
10.1177/00333549111260s214
复制
发表时间：
2011-07-01
影响因子：
3.3
通讯作者：
Rodewald, Lance E.
中科院分区：
文献类型：
--
作者：
Lindley, Megan C.;Smith, Philip J.;Rodewald, Lance E.
目标.我们比较了（1）有资格和没有资格从儿童疫苗（VFC）计划获得免费疫苗的青少年的特征和（2）符合VFC资格和不符合VFC资格的青少年中脑膜炎球菌结合物（MCV 4）、四价人乳头瘤病毒（HPV 4）和破伤风-白喉-无细胞百日咳（Tdap）疫苗的接种覆盖率。我们分析了2009年全国青少年免疫接种调查的数据，这是一项具有全国代表性的随机数字拨号调查，调查对象是13-17岁青少年的家庭（n= 20，066）。采用t检验评估社会人口学特征和提供者报告的疫苗接种覆盖率的差异。总体而言，32.1%（+/- 1.2%）的青少年符合VFC资格。符合VFC条件的青少年比不符合VFC条件的青少年更不可能是白色和生活在郊区，更有可能生活在贫困中，有年轻和受教育程度较低的母亲。在全国范围内，非VFC合格青少年中Tdap ≥ 1剂的覆盖率为57.1%（+/- 1.5%），MCV 4 ≥ 1剂的覆盖率为55.4%（+/- 1.5%），HPV 4 ≥ 1剂的覆盖率为43.2%（+/- 2.2%）。符合VFC条件的青少年中，Tdap ≥ 1剂的覆盖率为52.5%（+/-2.4%），MCV 4 ≥ 1剂的覆盖率为50.1%（+/- 2.4%），HPV 4 ≥ 1剂的覆盖率为46.6%（+/- 3.5%）。只有27.5%（+/- 1.8%）的非VFC合格青少年和25.0%（+/- 2.9%）的VFC合格青少年接受了≥ 3剂HPV 4。非VFC合格青少年的Tdap和MCV 4疫苗接种覆盖率显著较高，但一剂或三剂HPV 4疫苗接种覆盖率不高。与不符合VFC条件的青少年相比，符合VFC条件的青少年中某些推荐疫苗的覆盖率较低。需要继续监测青少年疫苗接种率，特别是符合自愿疫苗接种条件的人群的疫苗接种率，以确保所有青少年接受所有常规推荐的疫苗。
Objectives. We compared (1) characteristics of adolescents who are and are not entitled to receive free vaccines from the Vaccines for Children (VFC) program and (2) vaccination coverage with meningococcal conjugate (MCV4), quadrivalent human papillomavirus (HPV4), and tetanus-diphtheria-acellular pertussis (Tdap) vaccines among VFC-eligible and non-VFC-eligible adolescents.Methods. We analyzed data from the 2009 National Immunization Survey-Teen, a nationally representative, random-digit-dialed survey of households with adolescents aged 13-17 years (n=20,066). Differences in sociodemographic characteristics and provider-reported vaccination coverage were evaluated using t-tests.Results. Overall, 32.1% (+/- 1.2%) of adolescents were VFC-eligible. VFC-eligible adolescents were significantly less likely than non-VFC-eligible adolescents to be white and to live in suburban areas, and more likely to live in poverty and to have younger and less educated mothers. Nationally, coverage among non-VFC-eligible adolescents was 57.1% (+/- 1.5%) for >= 1 dose of Tdap, 55.4% (+/- 1.5%) for >= 1 dose of MCV4, and 43.2% (+/- 2.2%) for >= 1 dose of HPV4. Coverage among VFC-eligible adolescents was 52.5% (+/- 2.4%) for >= 1 dose of Tdap, 50.1% (+/- 2.4%) for >= 1 dose of MCV4, and 46.6% (+/- 3.5%) for >= 1 dose of HPV4. Only 27.5% (+/- 1.8%) of non-VFC-eligible adolescents and 25.0% (+/- 2.9%) of VFC-eligible adolescents received >= 3 doses of HPV4. Vaccination coverage was significantly higher among non-VFC-eligible adolescents for Tdap and MCV4, but not for one-dose or three-dose HPV4.Conclusions. Coverage with some recommended vaccines is lower among VFC-eligible adolescents compared with non-VFC-eligible adolescents. Continued monitoring of adolescent vaccination rates, particularly among VFC-eligible populations, is needed to ensure that all adolescents receive all routinely recommended vaccines.